By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. Likely, there isn’t anyone reading this column who doesn’t have an opinion about what the federal government should and should not pay for. It seems there are numerous federal programs that could probably be cut or reduced without having a negative impact on economic growth.Read more
News
For venture and economic development organizations like i2E, a key aspect of our responsibility is acceleration. It’s figuring how to find the best athletes, amp up their training, speed up the track, improve the car. We also measure and communicate the metrics of innovation progress over time by distributing an economic impact survey to our entire population of client companies every year. In March, we submitted the 2016 economic impact survey to 153 active clients.
It’s a rare moment that the leaders and scientists of Oklahoma’s bioscience industry can come together to share the collaborative spirit that is such a part of who they are and what they are creating. The annual OKBIO Summit and BioScience Awards dinner is one of those moments.
On March 24, OKBIO, the Greater OKC Chamber and PhRMA (representing the country’s leading biopharmaceutical research and discovery companies) are hosting a unique opportunity for Oklahomans, from doctors to patients, to learn more about the power and the working parts of clinical trials.
Draft2Digital, provides web-based author services for self-published writers with a focus on getting new books in front of readers instead of in the infamous “slush pile.”
When i2E was asked to manage the Oklahoma BioScience Association (OKBio) a couple of years ago, we welcomed the opportunity. The promise of Oklahoma’s bioscience sector is deep and wide. The economic impact statewide of bioscience exceeds $6.7 billion, supporting 51,000 Oklahoma jobs and annual revenues from Oklahoma bio companies of more than $4.1 billion.
